IP Library Patent Application 14235387
Patent Application
App. No. 14/235,387

SANDALWOOD OIL AND ITS USES RELATED TO SKIN DISORDERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/235,387
Abstract

Provided herein are compositions of sandalwood heartwood oil and methods of making and using such compositions.

Claims (73)

1 . A composition comprising:

(a) a therapeutically effective amount of sandalwood heartwood oil;

(b) sandalwood nut oil.

2 . The composition of claim 1 , further comprising an active agent selected from the group consisting of acetic acid, acetone, alcloxa, alcohol, alkyl isoquinolinium bromide, allantoin, allyl isothiocyanate, aloe vera, alum, aluminum chlorohydrex, aluminum hydroxide, aluminum sulfate, amiloxate, ammonia solution, ammoniated mercury, amyltricresois, an antibiotic, ascorbic acid, aspirin, bacitracin, basic fuchsin, beeswax, benzalkonium chloride, benzethonium chloride, benzocaine, benzoic acid, benzoxiquine, benzoyl peroxide, benzyl alcohol, bismuth subsalicylate, boric acid, calcium polysulfide, calcium thiosulfate, calcium undecylate, calcium undecylenate, calomel, camphor, camphorated metacresol, candicin, captan, chloral hydrate, chlorhydroxyquinoline (cloxyquin), chlorobutanol, chlorothymol, chloroxylenol, clioquinol, cloflucarban, clotrimazole, coal tar, colloidal oatmeal, copper undecylate, cresol, cyclomethycaine sulfate, dibenzothiophene, dichlorophen,erythromycin, estrone, ethohexadiol, eucalyptol, eugenol, fluorosalan, glycerin, haloprogin, hexachlorophene, hexylresorcinol, hydrocortisone preparations, hydrogen peroxide, iodine-containing ingredient, juniper tar, kaolin, lanolin, lauryl isoquinolinium bromide, mandelic acid, magnesium aluminum silicate, magnesium sulfate, m-cresol, methylparaben, menthol, merbromin, mercufenol chloride, mercuric chloride, mercuric oxide, mercuric salicylate, mercuric sulfide (red), mercury, mercury oleate, mercury sulfide, mercury-containing ingredient, methapyrilene hydrochloride, methyl salicylate, methylbenzethonium chloride, miconazole nitrate, mineral oil, neomycin, nitromersol, nonylphenoxypoly ethanol iodine, nystatin, oxyquinoline, oxyquinoline, oxyquinoline sulfate, PABA, para-chloromercuriphenol, peppermint oil, phenol, phenolate sodium, phenyl salicylate, phenylmercuric nitrate, pine tar, poloxamer 188, poloxamer-iodine complex, potassium, povidone-iodine, propionic acid, propylparaben, pyrilamine maleate, pyrithione zinc, resorcinol, resorcinol monoacetate, salicylamide, salicylic acid, selenium sulfide, shark liver oil, sodium borate, sodium caprylate, sodium propionate, sodium salicylate, sodium thiosulfate, sulfur, tannic acid, tetracaine, tetracaine hydrochloride, tetracycline, thimerosal, thymol, tolindate, tolnaftate, triacetin, triclocarban, triclosan, triple dye, undecoylium chlorideiodine complex, undecylenic acid, vitamin A, vitamin E, vitromersal, zinc acetate, zinc caprylate, zinc oxide, zinc propionate, zinc stearate, zinc sulfide, zinc undecylate, zyloxin and 2-ethylhexyl-4-phenylbenzopohenone-2-carboxylic acid.

3 . (canceled)

4 . (canceled)

5 . The composition of claim 1 , wherein the concentration of the sandalwood heartwood oil is greater than about 0.3% (w/w) to about 10% (w/w).

6 . The composition of claim 1 , wherein the concentration of the sandalwood nut oil is from about 0.5% to about 10% (w/w).

7 . The composition of claim 2 , wherein the concentration of the active ingredient is from about 0.25% to about 25% (w/w).

8 . The composition of claim 1 , further comprising a fruit acid.

9 . (canceled)

10 . The composition of claim 1 , further comprising a fruit extract.

11 . (canceled)

12 . The composition of claim 1 , further comprising a flower extract.

13 . (canceled)

14 . The composition of claim 1 , further comprising a solvent.

15 . (canceled)

16 . The composition of claim 14 , wherein the solvent is water or alcohol.

17 . (canceled)

18 . (canceled)

19 . (canceled)

20 . (canceled)

21 . (canceled)

22 . (canceled)

23 . The composition of claim 1 , wherein the composition is in a form selected from the group consisting of an ointment, lotion, cream, moisturizer, gel, mousse, clay mask, serum, cleanser, shaving cream, shaving gel, soap, shampoo and a stick.

24 . (canceled)

25 . (canceled)

26 . A method of treating a skin disorder in a subject comprising administering the composition of claim 1 to the subject, where the subject has a skin disorder or is at risk of developing a skin disorder.

27 . The method of claim 26 , wherein the skin disorder is selected from the group consisting of acne, rosacea, psoriasis, eczema, dermatitis, dandruff, diaper rash and fungal infection.

28 . (canceled)

29 . (canceled)

30 . (canceled)

31 . An anti-acne composition comprising:

(a) an active anti-acne agent;

(b) a fruit acid;

(c) sandalwood heartwood oil;

(d) a fruit extract; and

(e) a flower extract.

32 . The composition of claim 31 , wherein the active anti-acne agent is selected from the group consisting of salicylic acid, benzoyl peroxide, glycolic acid and sulfur.

33 . (canceled)

34 . (canceled)

35 . The composition of claim 31 , wherein the concentration of the heartwood oil is from about 0.25% to about 10% (w/w).

36 . (canceled)

37 . (canceled)

38 . The composition of claim 31 , further comprising a solvent.

39 . (canceled)

40 . (canceled)

41 . (canceled)

42 . (canceled)

43 . (canceled)

44 . (canceled)

45 . (canceled)

46 . (canceled)

47 . (canceled)

48 . An anti-acne composition comprising:

(a) an active anti-acne agent;

(b) sandalwood heartwood oil;

(c) flower extract; and

(d) lemon myrtle leaf extract.

49 . The composition of claim 48 , wherein the anti-acne agent is selected from the group consisting of salicylic acid, benzoyl peroxide, glycolic acid and sulfur.

50 . (canceled)

51 . (canceled)

52 . (canceled)

53 . (canceled)

54 . The composition of claim 48 , further comprising a solvent.

55 . (canceled)

56 . (canceled)

57 . (canceled)

58 . The composition of claim 31 , wherein the composition is in a form selected from the group consisting of an ointment, lotion, cream, moisturizer, gel, mousse, clay mask, serum, cleanser, shaving cream, shaving gel, shampoo, soap and a stick.

59 . (canceled)

60 . A method of treating acne in a subject comprising administering the composition of claim 31 to the subject, wherein the subject has acne or is at risk of developing acne.

61 . (canceled)

62 . (canceled)

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 23, 2018
From: BTA INSTITUTIONAL SERVICES AUSTRALIA LIMITED
To: SANTALIS HEALTHCARE CORPORATION; SANTALIS PHARMACEUTICALS, INC.
Reel/Frame 047282/0428 →
PATENT SECURITY AGREEMENT Recorded Aug 1, 2016
From: SANTALIS PHARMACEUTICALS, INC.; SANTALIS HEALTHCARE CORPORATION
To: BTA INSTITUTIONAL SERVICES AUSTRALIA LIMITED
Reel/Frame 039535/0701 →
RELEASE OF SECURITY INTEREST Recorded Jul 27, 2016
From: BTA INSTITUTIONAL SERVICES AUSTRALIA LIMITED
To: SANTALIS PHARMACEUTICALS, INC.; SANTALIS HEALTHCARE CORPORATION
Reel/Frame 039274/0410 →
SECURITY INTEREST Recorded Dec 30, 2015
From: SANTALIS PHARMACEUTICALS, INC.; SANTALIS HEALTHCARE CORPORATION
To: BTA INSTITUTIONAL SERVICES AUSTRALIA LIMITED
Reel/Frame 037386/0918 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2014
From: CLEMENTS, IAN; CASTELLA, PAUL; LEVENSON, COREY
To: SANTALIS PHARMACEUTICALS, INC.
Reel/Frame 032318/0001 →